Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 12-2023 | 09-2021 | |
| Sales | 0 | 101,620 | 100,049 | 0 | 100,827 |
| Cost of Goods | N/A | 57,208 | 62,495 | N/A | N/A |
| Gross Profit | N/A | 44,412 | 37,554 | N/A | 100,827 |
| Operating Expenses | 0 | 105,462 | 105,060 | 0 | 34,384 |
| Operating Income | N/A | -60,842 | -67,011 | N/A | 66,443 |
| Interest Expense | 0 | 13,799 | 13,674 | 0 | 11,458 |
| Other Income | 0 | 6,912 | 14,499 | 0 | -152 |
| Pre-tax Income | 0 | -67,729 | -66,186 | 0 | 54,833 |
| Income Tax | N/A | N/A | N/A | N/A | 3,678 |
| Net Income Continuous | N/A | -67,729 | -66,186 | N/A | 51,155 |
| Net Income | $N/A | $-67,729 | $-66,186 | $N/A | $51,155 |
| EPS Basic Total Ops | N/A | -2.59 | -2.54 | N/A | 2.82 |
| EPS Basic Continuous Ops | N/A | -1.90 | -1.87 | N/A | 2.82 |
| EPS Diluted Total Ops | N/A | -2.59 | -2.54 | N/A | 2.79 |
| EPS Diluted Continuous Ops | N/A | -1.90 | -1.87 | N/A | 2.79 |
| EPS Diluted Before Non-Recurring Items | N/A | N/A | 0.54 | N/A | 2.79 |
| EBITDA(a) | $N/A | $-48,484 | $-67,011 | $N/A | $100,149 |